Skip to main content
. 2018;19(10):2979–2984. doi: 10.22034/APJCP.2018.19.10.2979

Table 1.

Baseline Characteristics of the Study Participants

Characterstrics Total (n=45) Control Diet (n=22) GFD Diet (n=23) P-value
Age (years) 58.55±8.76a 59.57±8.84 57.11±8.23 0.101
Sex (female/male) 31/11 16/6 17/6 0.647
Height (cm) 159±8.77 159.78±8.74 159.63±9.04 0.957
Weight (kg) 80.82±13.41 82.21±13.61 77.73±8.74 0.206
BMI (kg/m2) 32.06±8.68 32.60±4.70 30.62±3.61 0.242
WC (cm) 103.26±8.68 104.65±10.13 101.57±6.28 0.832
FBS (mg/dl) 123.47±33.14 127.04±29.23 119.15±38.11 0.562
Insulin serum (mU/L) 12.05±5.75 11.57±5.79 12.63±5.80 0.56
HOMA-IR 3.62±1.65 3.56±1.76 3.70±1.86 0.814
Serum Lipids
 Total cholestrol (mg/dl) 170.47±36.43 170.82±38.91 170.05±34.24 0.946
 HDL (mg/dl) 46.33±11.86 46.64±7.83 45.56±15.56 0.724
 Triglycerides (mg/dl) 159.5±60.70 161.73±72.57 156.78±44.06 0.796
 LDL (mg/dl) 98.62±33.85 97.99±34.47 99.4±34.07 0.894
Blood pressure
 Systolic (mmHg) 14.06±1.09 14.10±1.04 14.02±1.17 0.806
 Diastolic (mmHg) 8.81±.53 8.89±.56 8.72±.49 0.315

WC, waist circumference; BMI, body mass index; FBS, fasting blood sugar; LDL, low density lipoprotein; HDL, high density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance;

a

Mean ± SD (all such values)